Precise estimation of cardiac patients' current and future comorbidities is an important factor in prioritizing continuous physiological monitoring and new therapies. ML models have shown satisfactory performance in short-term mortality prediction of patients with heart disease, while their utility in long-term predictions is limited. This study aims to investigate the performance of tree-based ML models on long-term mortality prediction and the effect of two recently introduced biomarkers on long-term mortality. This study utilized publicly available data from CCHIA at the Ministry of Health and Welfare, Taiwan, China. Medical records were used to gather demographic and clinical data, including age, gender, BMI, percutaneous coronary intervention (PCI) status, and comorbidities such as hypertension, dyslipidemia, ST-segment elevation myocardial infarction (STEMI), and non-STEMI. Using medical and demographic records as well as two recently introduced biomarkers, brachial pre-ejection period (bPEP) and brachial ejection time (bET), collected from 139 patients with acute myocardial infarction, we investigated the performance of advanced ensemble tree-based ML algorithms (random forest, AdaBoost, and XGBoost) to predict all-cause mortality within 14 years. The developed ML models achieved significantly better performance compared to the baseline LR (C-Statistic, 0.80 for random forest, 0.79 for AdaBoost, and 0.78 for XGBoost, vs 0.77 for LR) (P-RF<0.001, PAdaBoost<0.001, PXGBoost<0.05). Adding bPEP and bET to our feature set significantly improved the algorithms' performance, leading to an absolute increase in C-Statistic of up to 0.03 (C-Statistic, 0.83 for random forest, 0.82 for AdaBoost, and 0.80 for XGBoost, vs 0.74 for LR) (P-RF<0.001, PAdaBoost<0.001, PXGBoost<0.05). This advancement may enable better treatment prioritization for high-risk individuals.